Life360, Inc. — Director's Dealing 2021

Dec 14, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name	of	entity Life360, inc.
ARBN		629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alexander (Alex) Haro
Date of last notice	15 September 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 297] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Direct
Nature of indirect interest -
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 8 December 2021 (PST)
No. of securities held prior to change  1,777,780 shares of common stock
(Shares ) (equivalent to 5,333,340 Chess
Depositary Interests ( CDIs )
 1,140,687 CDIs
 386,938 Options overs Shares ( Options)
 91,905 CDIs held by ICCA Labs, LLC [1]
 1,349 Restricted Stock Units ( RSUs )
Class Shares & RSUs
Number acquired 450 Shares
----- End of picture text -----

1 Alex Haro is a member of ICCA Labs, LLC, an entity that holds Life360 CDIs. The number of CDIs attributable to Alex Haro by reason of his membership interest in ICCA Labs, LLC is 91,905

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	450 RSUs (having vested)
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Shares are issued following the vesting and settlement of 450 RSUs, which were granted in lieu of the payment of Directors’ Fees2
No. of securities held after change	 1,778,230 Shares (equivalent to 5,334,690 CDIs)  1,140,687 CDIs  386,938 Options  91,905 CDIs held by ICCA Labs, LLC  899 RSUs
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of Shares following the vesting and settlement of RSUs.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 285] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details and an
estimated valuation
----- End of picture text -----

2 As per Appendix 3Y lodged on 7 May 2021, 2,462 RSUs were granted in lieu of the payment of US$32,867 of Director and Committee fees. RSUs vest and are settled quarterly.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3